BackColgate-Palmolive Overview
Colgate-Palmolive Co.

Colgate-Palmolive Target Price

Analysts' average 12-month price target for Colgate-Palmolive is $99.

Get informed when a big investor buys or sells

+ Follow

Share Price

$92.93

Average Target Price

$98.706.2% upside

10 analysts in the last 4 months

High: $109 | Low: $79

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-03RBC CapitalNik Modi$10411.9% upsideOpen
2026-08-03Deutsche Bank$1018.7% upsideOpen
2026-08-03Morgan Stanley$10411.9% upsideOpen
2026-08-03UBS$10917.3% upsideOpen
2026-07-08Wells FargoChris Carey$952.2% upsideOpen
2026-06-11BernsteinCristian Rios$963.3% upsideOpen
2026-05-04UBS$1007.6% upsideOpen
2026-05-04Deutsche BankSteve Powers$996.5% upsideOpen
2026-04-21Redburn Partners$1007.6% upsideOpen
2026-04-14BarclaysLauren Lieberman$7915% downsideOpen
2026-04-09RBC Capital$1029.8% upsideOpen
2026-04-08Piper Sandler$921% downsideOpen
2026-04-08Wells FargoChris Carey$921% downsideOpen
2026-02-20Goldman SachsBonnie Herzog$1007.6% upsideOpen
2026-02-13Redburn Partners$930.1% upsideOpen
2026-02-03BarclaysLauren Lieberman$885.3% downsideOpen
2026-02-02Morgan StanleyDara Mohsenian$1007.6% upsideOpen
2026-02-01Wells Fargo$941.2% upsideOpen
2026-01-31Goldman SachsBonnie Herzog$941.2% upsideOpen
2026-01-30Piper Sandler$963.3% upsideOpen
2026-01-16BarclaysLauren Lieberman$8310.7% downsideOpen
2026-01-14UBSPeter Grom$930.1% upsideOpen
2026-01-13Wells Fargo$867.5% downsideOpen
2026-01-06Piper Sandler$885.3% downsideOpen
2025-12-16Jefferies$858.5% downsideOpen
2025-12-09RBC Capital$885.3% downsideOpen
2025-11-03Evercore ISIRobert Ottenstein$941.2% upsideOpen
2025-11-03Morgan StanleyDara Mohsenian$876.4% downsideOpen
2025-10-10Deutsche Bank$867.5% downsideOpen
2025-10-08UBS$921% downsideOpen
2025-10-03Piper Sandler$849.6% downsideOpen
2025-10-01BarclaysLauren Lieberman$8211.8% downsideOpen
2025-08-04Morgan Stanley$963.3% upsideOpen
2025-03-27Barclays$894.2% downsideOpen
2024-09-23Piper SandlerKorinne Wolfmeyer$12130.2% upsideOpen
2024-09-16Wells FargoChris Carey$1007.6% upsideOpen
2024-07-22Stifel NicolausMark Astrachan$10513% upsideOpen
2024-05-28Morgan StanleyDara Mohsenian$10310.8% upsideOpen
2024-05-15Argus ResearchChris Graja$10715.1% upsideOpen
2024-04-29Deutsche BankSteve Powers$985.5% upsideOpen
2024-04-29Stifel NicolausMark Astrachan$952.2% upsideOpen
2024-04-10Stifel NicolausMark Astrachan$941.2% upsideOpen
2024-04-08Evercore ISIRobert Ottenstein$963.3% upsideOpen
2024-01-29Raymond JamesOlivia Tong$912.1% downsideOpen
2023-07-28Wells FargoChris Casey$8112.8% downsideOpen
2023-01-13J.P. Morgan$867.5% downsideOpen
2023-01-03Barclays$8013.9% downsideOpen
2022-12-06Deutsche Bank$876.4% downsideOpen
2022-10-18Credit SuisseKaumil Gajrawala$858.5% downsideOpen
2022-10-03Wells Fargo$7519.3% downsideOpen

Colgate-Palmolive (CL) FAQ

As of the most recent data, CL shows a target price of $99. Scroll down for historical charts and peer comparison views.

If Colgate-Palmolive moved to the average analyst target of $99, shares would be roughly 6.2% higher than $92.93. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Colgate-Palmolive's earnings trajectory.

Besides this target price page, Stockcircle has Colgate-Palmolive's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $99) with ownership activity and broader fundamentals.

Colgate-Palmolive's target price is $99; compare it with other Consumer Staples names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.